7 Список литературы

69. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplastyin 170 consecutive patients. N Engl J Med 1988; 319:125-30.

70. Safian RD, Mandell VS, Thurer RE, et al. Postmortem andintraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am CollCardiol 1987; 9:655- 60.

71. Isner JM, Samuels DA, Slovenkai GA, et al. Mechanism of aorticballoon valvuloplasty: fracture of valvular calcific deposits. AnnIntern Med 1988; 108:377- 80.

72. Letac B, Cribier A, Koning R, Bellefleur JP. Results of percutaneoustransluminal valvuloplasty in 218 adults with valvular aortic stenosis.Am J Cardiol 1988; 62:598-605.

73. Sherman W, Hershman R, Lazzam C, Cohen M, Ambrose J,Gorlin R. Balloon valvuloplasty in adult aortic stenosis: determinantsof clinical outcome. Ann Intern Med 1989; 110:421-5.

74. Brady ST, Davis CA, Kussmaul WG, Laskey WK, Hirshfeld JW Jr,Herrmann HC. Percutaneous aortic balloon valvuloplasty in octogenarians:morbidity and mortality. Ann Intern Med 1989; 110:761-6.

75. Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS. Palliativepercutaneous aortic balloon valvuloplasty before noncardiac operationsand invasive diagnostic procedures. Mayo Clin Proc 1989; 64:753-7.

76. Fields CD, Rosenfield K, Lasordo DW, Isner JM. Percutaneousballoon valvuloplasty: current status. Curr Opinion Cardiol 1989; 4:229-42.

77. Ferguson JJ III, Riuli EP, Massumi A, et al. Balloon aorticvalvuloplasty: the Texas Heart Institute experience. Tex Heart InstJ 1990; 17:23-30.

78. Berland J, Cribier A, Savin T, Lefebvre E, Koning R, Letac B.Percutaneous balloon valvuloplasty in patients with severe aorticstenosis and low ejection fraction: immediate results and 1-yearfollow-up. Circulation 1989; 79: 1189 -96.

79. Davidson CJ, Harrison JK, Leithe ME, Kisslo KB, Bashore TM. Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function. Am J Cardiol 1990;65:72-7.

80. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcomeafter balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation 1994; 89:642-50.

81. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-termsurvival. J Am Coll Cardiol 1995; 26:1522- 8.

82. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994; 23:1076-8.

83. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597 - 1607.

84. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Trans- catheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187 - 2198.

85. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135:180 - 187

86. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pie'rard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Associ- ation of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 2008;29:1463 - 1470.

87. Christ M, Sharkova Y, Geldner G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128:2944 -53.

88. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J AmColl Cardiol 1997; 29:630-4.

89. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS.Association of aortic- valve sclerosis with cardiovascular mortalityand morbidity in the elderly. N Engl J Med 1999; 341:142

90 Olsen MH, Wachtell K, Bella JN, et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFEsubstudy). Am J Cardiol 2005;95:132- 6.

91. Taylor HA Jr, Clark BL, Garrison RJ, et al. Relation of aortic valve sclerosis to risk of coronary heart disease in African-Americans.Am J Cardiol 2005;95:401- 4.

92. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR. A case control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis.Heart 1997; 78:475-9.

93. Palta S, Pai AM, Gill KS, Pai RG. New insights into theprogression of aortic stenosis: implications for secondary prevention. Circulation 2000; 101:2497-502.

94. Ngo MV, Gottdiener JS, Fletcher RD, Fernicola DJ, Gersh BJ.Smoking and obesity are associated with the progression of aortic stenosis. Am J Geriatr Cardiol 2001; 10:86 -90.

95. Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004; 43:169 -75.

96. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation 2004; 110:1180 -2.

97. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mildvalvular aortic stenosis in older persons. Am J Cardiol 2001; 88:6935.

98. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL,Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductaseinhibitors on the progression of calcific aortic stenosis. Circulation2001; 104:2205-9.

99. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O’Brien KD.HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359:1125- 6.

100. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascularrisk factors. Circulation 2001; 104:1927-32.

101. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-SaranoM. Association of cholesterol levels, hydroxymethylglutarylcoenzyme-A reductase inhibitor treatment, and progression ofaortic stenosis in the community. J Am Coll Cardiol 2002; 40:1723-30.

102. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin converting enzyme inhibitors delay progression of aortic stenosis.Circulation 2004; 110:1291-5.

103. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial ofintensive lipid-lowering therapy in calcific aortic stenosis.N EnglJ Med 2005; 352:2389 - 97.

104. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S,Salamon R. European system for cardiac operative risk evaluation(EuroSCORE). Eur J Cardiothorac Surg 1999;16:9 -13.

105. Nashef SA, Roques F, Hammill BG, et al. Validation of EuropeanSystem for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002; 22:101-5.

106. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003; 75:1856-64.

107 Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, TaylorKM. Generic, simple risk stratification model for heart valve surgery.Circulation 2005; 112:224 -31.